Endo International Plc, the newest drugmaker impaired by opioid claims, needto choose whether to avoid more than $90 million in interest payments as it considers a possible insolvency filing.
Read More.
Endo International Plc, the newest drugmaker impaired by opioid claims, needto choose whether to avoid more than $90 million in interest payments as it considers a possible insolvency filing.
Read More.